Fukawa K, Nishimura N, Irino O, Nakazato K, Taguchi A, Nitta K
Gan To Kagaku Ryoho. 1982 May;9(5):915-23.
Effects of lysozyme(LY) alone and combination with various antitumor agents were examined using syngeneic tumors mainly Meth-A and MH 134 transplanted into Balb/c and C3H/He mice, respectively. The effects of LY on pulmonary metastases were also examined in BDF1 mice bearing Lewis lung carcinoma (3LL). LY inhibited the growth of Meth-A tumor and enhanced antitumor effects of mitomycin C (MMC). bleomycin (BLM) and 5-fluorouracil (5-FU), LY activated antitumor effects of MMC, BLM and 5-FU on MH 134 tumor, however, LY alone did not show any significant antitumor effect on it. The combination treatments using LY with MMC or 5-FU showed a marked inhibition on pulmonary metastases of 3LL. The pre-treatment of LY inhibited the tumor growth of Sarcoma-180 in ICR mice.
分别将同基因肿瘤(主要是移植到Balb/c小鼠体内的Meth-A肿瘤和移植到C3H/He小鼠体内的MH 134肿瘤),来研究单独使用溶菌酶(LY)以及其与各种抗肿瘤药物联合使用的效果。还在携带Lewis肺癌(3LL)的BDF1小鼠中研究了LY对肺转移的影响。LY抑制了Meth-A肿瘤的生长,并增强了丝裂霉素C(MMC)、博来霉素(BLM)和5-氟尿嘧啶(5-FU)的抗肿瘤作用。LY激活了MMC、BLM和5-FU对MH 134肿瘤的抗肿瘤作用,然而,单独使用LY对其没有显示出任何显著的抗肿瘤作用。LY与MMC或5-FU联合治疗对3LL的肺转移有明显抑制作用。LY预处理可抑制ICR小鼠肉瘤-180的肿瘤生长。